Maternal obesity during pregnancy leads to adipose tissue ER stress in mice via miR-126-mediated reduction in Lunapark.
3T3-L1 Cells
Adipocytes
/ metabolism
Adipose Tissue
/ metabolism
Animals
Blood Glucose
/ metabolism
Disease Models, Animal
Down-Regulation
Endoplasmic Reticulum Stress
Female
Homeodomain Proteins
/ genetics
Insulin Receptor Substrate Proteins
/ genetics
Insulin Resistance
Mice
Mice, Inbred C57BL
MicroRNAs
/ genetics
Obesity, Maternal
/ genetics
Phenotype
Pregnancy
Prenatal Exposure Delayed Effects
Signal Transduction
ER stress
Glucose metabolism
Lunapark
Maternal obesity
Nutritional programming
miR-126-3p
Journal
Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
04
08
2020
accepted:
26
10
2020
pubmed:
28
1
2021
medline:
16
2
2022
entrez:
27
1
2021
Statut:
ppublish
Résumé
Levels of the microRNA (miRNA) miR-126-3p are programmed cell-autonomously in visceral adipose tissue of adult offspring born to obese female C57BL/6J mice. The spectrum of miR-126-3p targets and thus the consequences of its dysregulation for adipocyte metabolism are unknown. Therefore, the aim of the current study was to identify novel targets of miR-126-3p in vitro and then establish the outcomes of their dysregulation on adipocyte metabolism in vivo using a well-established maternal obesity mouse model. miR-126-3p overexpression in 3T3-L1 pre-adipocytes followed by pulsed stable isotope labelling by amino acids in culture (pSILAC) was performed to identify novel targets of the miRNA. Well-established bioinformatics algorithms and luciferase assays were then employed to confirm those that were direct targets of miR-126-3p. Selected knockdown experiments were performed in vitro to define the consequences of target dysregulation. Quantitative real-time PCR, immunoblotting, histology, euglycaemic-hyperinsulinaemic clamps and glucose tolerance tests were performed to determine the phenotypic and functional outcomes of maternal programmed miR-126-3p levels in offspring adipose tissue. The proteomic approach confirmed the identity of known targets of miR-126-3p (including IRS-1) and identified Lunapark, an endoplasmic reticulum (ER) protein, as a novel one. We confirmed by luciferase assay that Lunapark was a direct target of miR-126-3p. Overexpression of miR-126-3p in vitro led to a reduction in Lunapark protein levels and increased Perk (also known as Eif2ak3) mRNA levels and small interference-RNA mediated knockdown of Lunapark led to increased Xbp1, spliced Xbp1, Chop (also known as Ddit3) and Perk mRNA levels and an ER stress transcriptional response in 3T3-L1 pre-adipocytes. Consistent with the results found in vitro, increased miR-126-3p expression in adipose tissue from adult mouse offspring born to obese dams was accompanied by decreased Lunapark and IRS-1 protein levels and increased markers of ER stress. At the whole-body level the animals displayed glucose intolerance. Concurrently targeting IRS-1 and Lunapark, a nutritionally programmed increase in miR-126-3p causes adipose tissue insulin resistance and an ER stress response, both of which may contribute to impaired glucose tolerance. These findings provide a novel mechanism by which obesity during pregnancy leads to increased risk of type 2 diabetes in the offspring and therefore identify miR-126-3p as a potential therapeutic target.
Identifiants
pubmed: 33501603
doi: 10.1007/s00125-020-05357-4
pii: 10.1007/s00125-020-05357-4
pmc: PMC7940301
doi:
Substances chimiques
Blood Glucose
0
Homeodomain Proteins
0
Insulin Receptor Substrate Proteins
0
Irs1 protein, mouse
0
Lnpk protein, mouse
0
MIRN126 microRNA, mouse
0
MicroRNAs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
890-902Subventions
Organisme : Medical Research Council
ID : MC_UU_12012/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A600_1024
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/17/12/33167
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M001636/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/5
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/4
Pays : United Kingdom
Références
Diabetes. 2011 Jan;60(1):47-55
pubmed: 20943748
Front Neurosci. 2017 Mar 24;11:152
pubmed: 28392758
Diabetes. 2008 Sep;57(9):2438-44
pubmed: 18567819
Cardiovasc Res. 2018 Aug 1;114(10):1372-1384
pubmed: 29635288
Nat Cell Biol. 2012 Jun 24;14(7):707-16
pubmed: 22729086
Diabetes. 2007 Dec;56(12):2910-8
pubmed: 17848624
EMBO Rep. 2006 Sep;7(9):880-5
pubmed: 16953201
Br J Nutr. 2014 Jun 28;111(12):2112-22
pubmed: 24666709
Science. 2004 Oct 15;306(5695):457-61
pubmed: 15486293
Cell. 2009 Feb 20;136(4):642-55
pubmed: 19239886
Int J Obes (Lond). 2018 Apr;42(4):618-624
pubmed: 29158541
Methods Mol Biol. 2011;732:139-52
pubmed: 21431711
Cell. 2013 Apr 25;153(3):516-9
pubmed: 23622238
BMC Med Genomics. 2010 Jan 27;3:3
pubmed: 20105310
Int J Obes (Lond). 2006 Jun;30(6):877-83
pubmed: 16418758
Nat Commun. 2018 Jul 30;9(1):2973
pubmed: 30061690
Mol Metab. 2018 Sep;15:8-19
pubmed: 29773464
Hypertension. 2008 Feb;51(2):383-92
pubmed: 18086952
Int J Obes (Lond). 2015 Apr;39(4):633-41
pubmed: 25640766
Int J Obes (Lond). 2013 Apr;37(4):568-75
pubmed: 22614057
Endocrinology. 2016 Nov;157(11):4246-4256
pubmed: 27583789
BMC Med. 2017 Mar 7;15(1):50
pubmed: 28264723
J Clin Endocrinol Metab. 2007 Jun;92(6):2292-9
pubmed: 17356053
JAMA. 2016 Mar 15;315(11):1129-40
pubmed: 26978208
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):418-23
pubmed: 25548161
Nature. 2006 Dec 14;444(7121):840-6
pubmed: 17167471
Circulation. 2011 Jul 5;124(1):67-76
pubmed: 21670228
Biochim Biophys Acta. 2013 Dec;1833(12):3460-3470
pubmed: 23850759
Mol Metab. 2014 Jan 20;3(3):325-33
pubmed: 24749062
Autophagy. 2015 Nov 2;11(11):1956-1977
pubmed: 26389781
Int J Obes (Lond). 2016 Feb;40(2):229-38
pubmed: 26367335
Diabetes. 2001 Nov;50(11):2585-90
pubmed: 11679438
Diabetologia. 2008 Aug;51(8):1466-74
pubmed: 18504545
Methods Mol Biol. 2017;1546:149-159
pubmed: 27896764